Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways

por Huang, Yanjun, Zhou, Sichun, He, Caimei, Deng, Jun, Tao, Ting, Su, Qiongli, Darko, Kwame Oteng, Peng, Mei, Yang, Xiaoping
Publicado 2018

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk

por Peng, Mei, Huang, Yanjun, Tao, Ting, Peng, Cai-Yun, Su, Qiongli, Xu, Wanjun, Darko, Kwame Oteng, Tao, Xiaojun, Yang, Xiaoping
Publicado 2016

A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3′,4′-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway

por Tao, Ting, He, Caimei, Deng, Jun, Huang, Yanjun, Su, Qiongli, Peng, Mei, Yi, Meiling, Darko, Kwame Oteng, Zou, Hui, Yang, Xiaoping
Publicado 2017

Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer

por Su, Qiongli, Tao, Ting, Tang, Lei, Deng, Jun, Darko, Kwame Oteng, Zhou, Sichun, Peng, Mei, He, Shanping, Zeng, Qing, Chen, Alex F., Yang, Xiaoping
Publicado 2018